Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

NPL3 is an Antagonist of Transcription Termination by RNA Polymerase II

NPL3 is an Antagonist of Transcription Termination by RNA Polymerase II. EMBO (submitted). 2005.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.